https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23937 age= 64.4 ± 11.1 years, 63.2 % male, and 82.2 % having localized kidney cancer. In the final multivariate model, meeting PA guidelines was associated with disease stage (OR = 0.25, p =.005), having drug therapy (OR = 3.98, p =.009), higher levels of instrumental attitudes (OR = 1.66, p =.053), higher levels of intention (OR = 1.72, p =.002), and the perceived presence of many retail shops in the neighborhood (OR = 1.37, p =.032). Conclusions: Meeting PA guidelines in KCS were associated with various aspects of the social-ecological model. Implications for Cancer Survivors: Understanding the social-ecological correlates for PA can provide insight into future interventions designed to increase PA in KCS. Prime targets for PA promotion should consider treatment-related factors, promote the benefits of PA, and enhance positive perceptions of the built environment.]]> Wed 09 Mar 2022 16:02:22 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50154 Wed 05 Jul 2023 14:26:05 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36667 2 standard alcoholic drinks/day (41.2%). In conclusion, large fractions of kidney and bladder cancers in Australia are preventable by behavior change.]]> Tue 26 Jul 2022 11:43:54 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20786 Sat 24 Mar 2018 08:06:01 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19456 Sat 24 Mar 2018 08:02:24 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27590 Sat 24 Mar 2018 07:23:41 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51497 A (p.P.A148T) and survival of patients with bladder or kidney cancer remains controversial. Materials and Methods: We compared the allele frequencies of NOD2 c.3020insC and CDKN2A p.A148T allele in 706 patients with bladder cancer, 410 cases with kidney cancer against two control groups. The Cox proportional hazards model was used to determine whether there were any survival differences between carriers of the NOD2 c.3020insC or the CDKN2A p.A148T variant. Results: Among the three patient subgroups: patients under 60 years of age, non-smokers and a third with histological features of low grade noninvasive papillary bladder cancer, we observed that the c.3020insC allele had a nominal statistically significant effect on survival. We also observed that the NOD2 c.3020insC variant was more frequent in patients with bladder cancer aged between 51 and 60 years. There was some nominal evidence that the CDKN2A p.A148T polymorphism reduced survival in the subgroup of bladder cancer patients under 60 years of age. We observed that in kidney cancer patients, the incidence of the NOD2 variant appeared to be lower in the group aged between 60 and 70 years, however, this was not statistically significant. In addition, in patients with histological features of grade III chromophobic kidney cancer, the c.3020insC allele also appeared to be overrepresented but this too was not statistically significant. Conclusion: We have shown that the NOD2 c.3020insC allele and the CDKN2A p.A148T polymorphism does not play a role in the survival of patients with bladder cancer.]]> Fri 08 Sep 2023 11:56:10 AEST ]]>